Tiziana Life Sciences Secures ALS Association Grant
Ticker: TLSA · Form: 6-K · Filed: Nov 19, 2024 · CIK: 1723069
Sentiment: bullish
Topics: grant, biotech, als, funding
TL;DR
Tiziana Life Sciences just got a grant from the ALS Association for their research. Big news for ALS drug development.
AI Summary
Tiziana Life Sciences LTD announced on November 19, 2024, that its grant application to the ALS Association has been approved for funding. This grant is part of the Hoffman ALS Clinical Trial Awards Program and is specifically for research titled "Modulation of". The exact dollar amount of the grant was not disclosed in this filing.
Why It Matters
This funding from the ALS Association could accelerate Tiziana's research into potential treatments for Amyotrophic Lateral Sclerosis (ALS), a devastating neurodegenerative disease.
Risk Assessment
Risk Level: medium — While the grant is positive, the filing does not disclose the amount or specific details of the research, and Tiziana Life Sciences operates in the highly competitive and regulated pharmaceutical sector.
Key Players & Entities
- Tiziana Life Sciences LTD (company) — The company filing the report and recipient of the grant.
- ALS Association (company) — The organization awarding the grant.
- Hoffman ALS Clinical Trial Awards Program (company) — The specific program under which the grant was awarded.
- November 19, 2024 (date) — The date of the announcement.
FAQ
What is the specific dollar amount of the grant awarded by the ALS Association?
The filing does not specify the exact dollar amount of the grant awarded by the ALS Association.
What is the full title of the research project that received the grant?
The filing states the research is titled "Modulation of", but the full title is not provided.
When was the grant application approved and announced?
The grant application was approved and announced on November 19, 2024.
Which specific program within the ALS Association is providing the funding?
The grant is awarded as part of the Hoffman ALS Clinical Trial Awards Program.
What is Tiziana Life Sciences LTD's primary business sector?
Tiziana Life Sciences LTD is in the Pharmaceutical Preparations sector, SIC code 2834.
Filing Stats: 378 words · 2 min read · ~1 pages · Grade level 14.3 · Accepted 2024-11-19 07:00:27
Filing Documents
- ea0221767-6k_tiziana.htm (6-K) — 20KB
- ea022176701ex99-1_tiziana.htm (EX-99.1) — 14KB
- ex99-1_001.jpg (GRAPHIC) — 3KB
- 0001213900-24-099821.txt ( ) — 39KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. TIZIANA LIFE SCIENCES LTD Date: November 19, 2024 By: /s/ Keeren Shah Name: Keeren Shah Title: Chief Financial Officer 2 EXHIBIT INDEX Exhibit No. Description 99.1 Tiziana Life Sciences LTD Press Release, dated November 19, 2024 3